Fibrous tissue of subchondral cystic lesions in horses produce local mediators and neutral metalloproteinases and cause bone resorption in vitro.
Authors: von Rechenberg B, Guenther H, McIlwraith C W, Leutenegger C, Frisbie D D, Akens M K, Auer J A
Journal: Veterinary surgery : VS
Summary
Subchondral cystic lesions (SCLs) in horses represent a significant orthopaedic challenge, yet their underlying pathophysiology remains incompletely understood; von Rechenberg and colleagues investigated whether the fibrous tissue lining these lesions actively drives bone destruction by measuring inflammatory mediators and enzymes in cultured explant tissue from affected horses. The researchers compared fibrous tissue from SCLs in multiple locations (femoral condyle, distal metacarpus, tarsus) against normal joint tissue and cartilage from horses with varying degrees of osteoarthritis, measuring nitric oxide (NO), prostaglandin E2 (PGE2), and neutral metalloproteinases (NMPs), whilst also assessing whether conditioned media from cystic tissue could recruit and activate osteoclasts in vitro. Fibrous tissue from SCLs produced all three inflammatory mediators, with PGE2 concentrations substantially elevated compared to normal and osteoarthritic tissue, and crucially, the conditioned media actively recruited osteoclasts and enhanced their bone-resorbing capacity. These findings fundamentally shift our understanding of SCL pathogenesis: rather than being inert cavitations, the fibrous lining actively perpetuates bone loss through local production of potent inflammatory mediators and bone-degrading enzymes, which may explain their characteristically poor healing and progressive enlargement. For practitioners, this mechanistic insight suggests that effective SCL management must target not merely the structural defect but also the inflammatory microenvironment—informing development of novel therapeutics and supporting the rationale for more aggressive early intervention before extensive cystic enlargement occurs.
Read the full abstract on PubMed
Practical Takeaways
- •Conservative management of SCL may fail because the fibrous tissue lining the cyst actively produces bone-resorbing factors; understanding this pathophysiology supports consideration of more aggressive interventions like debridement or injection therapies.
- •The high local PGE2 production suggests anti-inflammatory treatments targeting prostaglandin pathways warrant investigation as adjunctive therapies alongside mechanical treatments.
- •Lesions that appear stable radiographically may still be biologically active due to ongoing mediator production; clinical monitoring should not rely solely on imaging.
Key Findings
- •Fibrous tissue from subchondral cystic lesions produced significantly elevated prostaglandin E2 (PGE2) compared to normal joints and chip fracture tissue, suggesting a primary role in pathological bone resorption.
- •Conditioned media from SCL fibrous tissue recruited osteoclasts and increased their activity in vitro, indicating direct involvement in bone resorption mechanisms.
- •SCL fibrous tissue released nitric oxide, PGE2, and neutral metalloproteinases into culture media, suggesting these mediators actively maintain and expand cystic lesions.
- •The intralesional fibrous tissue appears to play an active role in the slow healing rate and progressive expansion characteristic of subchondral cystic lesions.